₹1656.8
0.11%
Low
Day's Volatility:0.21%
High
0.10%
45.68%
Low
52 Weeks Volatility:49.01%
High
3.33%
Returns % | |
1 Month Return | 11.99 % |
3 Month Return | 13.86 % |
1 Year Return | 76.82 % |
Market Stats | |
Previous Close | ₹1,657.65 |
Open | ₹1,655.00 |
Volume | 1.36L |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹17,440.57Cr |
based on 5 analysts
Based on 5 analysts offering long term price targets for Concord Biotech Ltd. An average target of ₹1596.8
Source: S&P Global Market Intelligence
Organisation | Concord Biotech Ltd |
Headquarters | Ahmedabad |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Key events for Concord Biotech Ltd
Concord Biotech Ltd registered a volume of 6.3 lakh shares, a 9.53 fold spurt over two-week average daily volume of 66087 shares. The stock rose 5.71% to Rs.1,596.70.
Concord Biotech's Profitability Metrics Improve YoY - 29 Mar, 2024
Concord Biotech Ltd reported an 8% decrease in revenue and a net profit decline of 11% from Q2 to Q3. However, the company's profitability metrics improved YoY with RoE increasing from 16.95% to 19.85%, RoCE zooming from 21.86% to 26.42%, and net profit margin increasing from 25.05% to 27.91%.
Fundamentals of Concord Biotech Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
MF Holding Up
Mutual Funds have increased holdings from 5.58% to 5.65% in Dec 2023 quarter
Price Rise
In the last 7 days, CONCORDBIO stock has moved up by 2.5%
Retail Holding Up
Retail Investor have increased holdings from 40.44% to 40.46% in Dec 2023 quarter
Promoter Holding Unchanged
Promoters holdings remained unchanged at 44.08% of holdings in Dec 2023 quarter
Profit Down
Netprofit is down for the last 2 quarters, 81.02 Cr → 77.57 Cr (in ₹), with an average decrease of 4.3% per quarter
Revenue Fall
Revenue is down for the last 2 quarters, 270.47 Cr → 252.0 Cr (in ₹), with an average decrease of 6.8% per quarter
FII Holding Down
Foreign Institutions have decreased holdings from 7.30% to 7.00% in Dec 2023 quarter
Concord Biotech Ltd in the last 5 years
Lowest (36.27x)
October 4, 2023
Today (57.27x)
April 30, 2024
Industry (62.57x)
April 30, 2024
Highest (57.27x)
April 30, 2024
Investors | Holdings % | Prev. 1 periods | 3M change |
---|---|---|---|
Promoter Holdings | 44.08% | 0.00 | |
Foreign Institutions | 6.48% | 0.00 | |
Mutual Funds | 5.15% | 0.00 | |
Retail Investors | 40.97% | 0.00 | |
Others | 3.32% | 0.00 |
Technicals of Concord Biotech Ltd share
News & Events of Concord Biotech Ltd
Concord Biotech Ltd (CONCORDBIO) share price today is ₹1656.8
Concord Biotech Ltd is listed on NSE
Concord Biotech Ltd is listed on BSE
PE Ratio of Concord Biotech Ltd is 57.27
PE ratio = Concord Biotech Ltd Market price per share / Concord Biotech Ltd Earnings per share
Today’s traded volume of Concord Biotech Ltd(CONCORDBIO) is 1.36L.
Today’s market capitalisation of Concord Biotech Ltd(CONCORDBIO) is ₹17440.57Cr.
Concord Biotech Ltd(CONCORDBIO | Price |
---|---|
52 Week High | ₹1711.95 |
52 Week Low | ₹900 |
Concord Biotech Ltd(CONCORDBIO) share price is ₹1656.8. It is down -3.22% from its 52 Week High price of ₹1711.95
Concord Biotech Ltd(CONCORDBIO) share price is ₹1656.8. It is up 84.09% from its 52 Week Low price of ₹900
Concord Biotech Ltd(CONCORDBIO | Returns |
---|---|
1 Day Returns | -10.3% |
1 Month Returns | 11.99% |
3 Month Returns | 13.86% |
1 Year Returns | 76.82% |